Watson Pharmaceuticals, Inc. (WPI) announced its subsidiary Watson Laboratories, Inc. has received approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Sildenafil Tablets, 20 mg, the generic equivalent to Pfizer's Revatio. Watson intends to begin shipping the product in the near future.
Revatio is indicated for the treatment of pulmonary arterial hypertension in adults to improve exercise ability and delay clinical worsening. For the 12 months ending September 30, 2012, Revatio tablets had total U.S. sales of approximately $339 million.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.